Capstone Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22M Buy
62,600
+15,500
+33% +$5.53M 0.04% 158
2025
Q4
$15.4M Sell
47,100
-24,600
-34% -$7.8M 0.03% 207
2025
Q3
$20.2M Buy
71,700
+34,900
+95% +$10.1M 0.04% 199
2025
Q2
$10.3M Sell
36,800
-41,600
-53% -$11.8M 0.03% 241
2025
Q1
$24.4M Sell
78,400
-54,900
-41% -$16.2M 0.06% 143
2024
Q4
$34.7M Buy
133,300
+47,000
+54% +$13.9M 0.08% 140
2024
Q3
$27.8M Buy
86,300
+12,900
+18% +$4.22M 0.08% 139
2024
Q2
$22.9M Buy
73,400
+43,100
+142% +$12.7M 0.07% 168
2024
Q1
$8.61M Sell
30,300
-32,100
-51% -$9.39M 0.03% 309
2023
Q4
$18M Buy
62,400
+23,400
+60% +$6.38M 0.05% 228
2023
Q3
$10.5M Buy
39,000
+8,600
+28% +$2.15M 0.05% 266
2023
Q2
$6.75M Buy
30,400
+9,300
+44% +$2.16M 0.03% 315
2023
Q1
$5.1M Sell
21,100
-42,500
-67% -$10.4M 0.03% 358
2022
Q4
$16.7M Buy
63,600
+4,700
+8% +$1.26M 0.12% 138
2022
Q3
$13.3M Sell
58,900
-800
-1% -$194K 0.08% 179
2022
Q2
$14.5M Sell
59,700
-161,100
-73% -$39.5M 0.07% 182
2022
Q1
$53.4M Sell
220,800
-300,100
-58% -$69M 0.15% 102
2021
Q4
$117M Buy
520,900
+45,900
+10% +$9.69M 0.2% 96
2021
Q3
$101M Sell
475,000
-47,300
-9% -$10.9M 0.2% 100
2021
Q2
$127M Buy
522,300
+40,700
+8% +$10M 0.29% 79
2021
Q1
$120M Buy
481,600
+134,500
+39% +$32.1M 0.35% 56
2020
Q4
$79.8M Buy
347,100
+12,800
+4% +$2.95M 0.27% 64
2020
Q3
$85M Buy
334,300
+121,600
+57% +$30.1M 0.43% 35
2020
Q2
$50.2M Buy
212,700
+158,100
+290% +$36.1M 0.33% 42
2020
Q1
$11.1M Sell
54,600
-292,100
-84% -$63.8M 0.18% 115
2019
Q4
$83.6M Buy
346,700
+119,900
+53% +$26.4M 0.45% 34
2019
Q3
$43.9M Buy
226,800
+56,700
+33% +$10.9M 0.3% 67
2019
Q2
$31.3M Buy
170,100
+23,800
+16% +$4.26M 0.23% 100
2019
Q1
$27.8M Buy
146,300
+74,100
+103% +$14.2M 0.26% 86
2018
Q4
$14.1M Buy
72,200
+23,600
+49% +$4.6M 0.17% 92
2018
Q3
$10.1M Buy
48,600
+35,100
+260% +$6.92M 0.12% 147
2018
Q2
$2.49M Buy
13,500
+12,600
+1,400% +$2.23M 0.04% 250
2018
Q1
$153K Buy
+900
New +$165K ﹤0.01% 318
2017
Q2
Sell
-12,400
Closed -$2.03M 626
2017
Q1
$2.03M Sell
12,400
-1,000
-7% -$166K 0.05% 281
2016
Q4
$1.96M Buy
+13,400
New +$2.02M 0.06% 285
2014
Q1
Sell
-95,900
Closed -$10.9M 375
2013
Q4
$10.9M Sell
95,900
-19,700
-17% -$2.24M 0.12% 98
2013
Q3
$12.9M Buy
115,600
+84,200
+268% +$9.13M 0.13% 87
2013
Q2
$3.1M Buy
+31,400
New +$3.26M 0.03% 195

Other funds holding AMGN

Capstone Investment Advisors's AMGN Position: Q1 2026 in Review

Capstone Investment Advisors opened a new position in Amgen (AMGN) in Q1 2026: 1,702 shares worth $599K. The stake represents ﹤0.01% of the portfolio and ranks #1068 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in AMGN as recently as Q3 2025.

Capstone Investment Advisors first reported a position in AMGN in Q3 2013 and has held it in 30 quarters since. The position peaked at $29.7M in Q3 2021. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Capstone Investment Advisors held 1,702 shares of Amgen worth $599K as of Q1 2026.
  • Amgen was a new Capstone Investment Advisors position in Q1 2026.
  • Amgen made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1068 holding.
  • Capstone Investment Advisors first reported a position in Amgen in Q3 2013 and has held it in 30 quarters since.
  • Capstone Investment Advisors's Amgen position peaked at $29.7M in Q3 2021.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.